Chinese Health Tech Giant Delays US IPO Amid DiDi Fallout
Hong Kong To Take Up Slack?
Big data player and “Flatiron of China” is putting off its plans to go public amid regulatory scrutiny over DiDi and other companies listed in the US, but biotech firms need to worry less, says one investor.
